Could a common prostate drug make surgery safer?
NCT ID NCT07417449
Summary
This study looks back at medical records to see if men who took dutasteride for at least six months before a specific prostate surgery (HoLEP) had different outcomes. Researchers will compare two groups: those who took the drug long-term and those who did not. The goal is to understand if the drug affects surgical bleeding, operation time, and how efficiently prostate tissue is removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC HYPERPLASIA, BENIGN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.